[1]
“Pharmacoeconomic analysis of long term use of darbepoetin-α in treating chronic nephropathy-induced anemia in dialysed patients”, FE, vol. 8, no. 2, pp. 61–69, Jun. 2007, doi: 10.7175/fe.v8i2.242.